Eliquis (Apixaban): A Comprehensive Guide to Its Uses, Benefits, and Safety

Eliquis (Apixaban): A Comprehensive Guide to Its Uses, Benefits, and Safety

Eliquis, known generically as apixaban, is a widely prescribed oral anticoagulant (blood thinner) that plays a crucial role in preventing and treating various blood clot-related conditions. Developed by Bristol-Myers Squibb and Pfizer, Eliquis has become a cornerstone in managing thromboembolic disorders due to its efficacy and safety profile.

What Is Eliquis?

Eliquis belongs to a class of medications called direct oral anticoagulants (DOACs). Specifically, it is a direct Factor Xa inhibitor, which means it selectively blocks the activity of Factor Xa, an essential enzyme in the blood coagulation cascade. By inhibiting this enzyme, Eliquis reduces the formation of blood clots, thereby lowering the risk of stroke and other clot-related complications.

Approved Uses of Eliquis

Eliquis is approved for several indications:

  1. Prevention of Stroke in Nonvalvular Atrial Fibrillation (NVAF): Eliquis reduces the risk of stroke and systemic embolism in patients with NVAF, a type of irregular heartbeat not caused by a heart valve problem.
  2. Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE): Eliquis is used to treat blood clots in the veins of the legs (DVT) and lungs (PE), and to reduce the risk of them occurring again. 
  3. Prevention of DVT and PE After Hip or Knee Replacement Surgery: Eliquis is indicated to reduce the risk of forming a blood clot in the legs and lungs of people who have just had hip or knee replacement surgery.

Dosage and Administration

Eliquis is available in 2.5 mg and 5 mg oral tablets. The dosing regimen varies based on the condition being treated:

  • For NVAF: The typical dose is 5 mg taken orally twice daily. A reduced dose of 2.5 mg twice daily may be recommended for patients with certain risk factors, such as advanced age, low body weight, or impaired kidney function.
  • For DVT and PE Treatment: An initial dose of 10 mg taken orally twice daily for 7 days, followed by 5 mg twice daily.
  • For DVT and PE Prevention After Initial Therapy: 2.5 mg taken orally twice daily.
  • After Hip or Knee Replacement Surgery: 2.5 mg taken orally twice daily, starting 12 to 24 hours after surgery. The duration of therapy is typically 35 days for hip replacement and 12 days for knee replacement.

It's important to take Eliquis exactly as prescribed, without missing doses, to maintain its effectiveness.

Benefits of Eliquis

Eliquis offers several advantages over traditional anticoagulants:

  • Predictable Pharmacokinetics: Eliquis has a predictable anticoagulant effect, allowing for fixed dosing without the need for routine blood monitoring.
  • Lower Risk of Intracranial Hemorrhage: Studies have shown that Eliquis has a lower risk of causing bleeding in the brain compared to warfarin, a traditional anticoagulant.
  • Fewer Food and Drug Interactions: Eliquis has fewer interactions with food and other medications, simplifying its use in daily life.

Safety and Side Effects

While Eliquis is generally well-tolerated, it can cause side effects:

  • Common Side Effects: Bleeding, including nosebleeds, bruising, and bleeding gums.
  • Serious Side Effects: Severe bleeding, allergic reactions, and liver enzyme abnormalities.

Patients should seek immediate medical attention if they experience signs of serious bleeding, such as prolonged bleeding, blood in urine or stool, or coughing up blood.

Precautions and Contraindications

Eliquis is not suitable for everyone. Precautions include:

  • Kidney and Liver Impairment: Dose adjustments may be necessary for patients with kidney or liver problems.
  • Surgery and Invasive Procedures: Eliquis should be discontinued prior to certain surgical or invasive procedures to reduce the risk of bleeding.
  • Pregnancy and Breastfeeding: The safety of Eliquis during pregnancy and breastfeeding has not been established.

Patients should inform their healthcare provider of all medical conditions and medications they are taking to assess the suitability of Eliquis.

Drug Interactions

Eliquis can interact with other medications, potentially increasing the risk of bleeding or reducing its effectiveness. Notable interactions include:

  • Antiplatelet Agents: Such as aspirin or clopidogrel.
  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Such as ibuprofen or naproxen.
  • Other Anticoagulants: Such as warfarin or heparin.
  • Certain Antifungal and Antiviral Medications: Such as ketoconazole or ritonavir.

Patients should consult their healthcare provider before starting or stopping any medications while taking Eliquis.

Storage and Handling

Eliquis should be stored at room temperature, away from moisture and heat. Keep the medication in its original container, tightly closed, and out of reach of children.

Conclusion

Eliquis (apixaban) is a vital medication in the prevention and treatment of blood clots, offering a favorable safety profile and ease of use compared to traditional anticoagulants. As with any medication, it's essential to use Eliquis under the guidance of a healthcare provider, adhering to prescribed dosages and monitoring for potential side effects.

For more information or to purchase Eliquis, you can visit MyRxUs.

 

Back to blog